Ustekinumab (Stelara) for psoriasis

MeSH terms

• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Dermatologic Agents / administration & dosage
• Dermatologic Agents / adverse effects
• Dermatologic Agents / therapeutic use*
• Humans
• Neoplasms / chemically induced
• Posterior Leukoencephalopathy Syndrome / chemically induced
• Psoriasis / drug therapy*
• Psoriasis / immunology
• Severity of Illness Index
• Treatment Outcome
• Ustekinumab